AJANTA PHARMAAJANTA PHARMAAJANTA PHARMA

AJANTA PHARMA

No trades
See on Supercharts
Market capitalization
‪260.07 B‬INR
‪5.88 B‬INR
‪37.28 B‬INR
‪42.54 M‬
Beta (1Y)
−0.53

About AJANTA PHARMA

Headquarters
Mumbai
Employees (FY)
‪10.27 K‬
Founded
1973
ISIN
INE031B01049
FIGI
BBG000CQGCV0
Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm offers branded generics and generics that serve a range of therapeutic segments such as antibiotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory, and general health. It operates through the following geographical segments: India, Africa, Asia, and USA. The company was founded by Purushottam Bhagwand Agrawal in 1973 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AJANTPHARM is 2078.85 INR — it has increased by 0.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AJANTA PHARMA stocks are traded under the ticker AJANTPHARM.
AJANTA PHARMA is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
AJANTPHARM stock is 2.11% volatile and has beta coefficient of −0.53. Check out the list of the most volatile stocks — is AJANTA PHARMA there?
One year price forecast for AJANTA PHARMA has a max estimate of 2561.00 INR and a min estimate of 1748.00 INR.
AJANTPHARM earnings for the last quarter are 15.50 INR whereas the estimation was 15.90 INR which accounts for −2.52% surprise. Estimated earnings for the next quarter are 15.33 INR. See more details about AJANTA PHARMA earnings.
AJANTA PHARMA revenue for the last quarter amounts to ‪10.28 B‬ INR despite the estimated figure of ‪10.49 B‬ INR. In the next quarter revenue is expected to reach ‪10.53 B‬ INR.
Yes, you can track AJANTA PHARMA financials in yearly and quarterly reports right on TradingView.
AJANTPHARM stock has fallen by 3.34% compared to the previous week, the month change is a 2.63% fall, over the last year AJANTA PHARMA has showed a 62.28% increase.
AJANTPHARM net income for the last quarter is ‪2.10 B‬ INR, while the quarter before that showed ‪1.95 B‬ INR of net income which accounts for 7.54% change. Track more AJANTA PHARMA financial stats to get the full picture.
Today AJANTA PHARMA has the market capitalization of ‪260.07 B‬, it has decreased by 5.85% over the last week.
AJANTA PHARMA dividend yield was 0.58% in 2022, and payout ratio reached 15.25%. The year before the numbers were 0.53% and 11.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AJANTPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AJANTA PHARMA stock right from TradingView charts — choose your broker and connect to your account.
AJANTPHARM reached its all-time high on Jan 4, 2024 with the price of 2353.95 INR, and its all-time low was 1.80 INR and was reached on Mar 28, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪10.27 K‬ employees. See our rating of the largest employees — is AJANTA PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AJANTA PHARMA technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AJANTA PHARMA stock shows the buy signal. See more of AJANTA PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AJANTA PHARMA future price: according to them, AJANTPHARM price has a max estimate of 2561.00 INR and a min estimate of 1748.00 INR. Read a more detailed AJANTA PHARMA forecast: see what analysts think of AJANTA PHARMA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AJANTA PHARMA EBITDA is ‪10.65 B‬ INR, and current EBITDA margin is 22.57%. See more stats in AJANTA PHARMA financial statements.